aica ribonucleotide and naltrexone

aica ribonucleotide has been researched along with naltrexone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
An, R; Fan, R; Feng, N; Gu, X; Guo, H; Jia, M; Li, J; Pei, J; Tian, X; Yang, L; Zhang, S; Zhao, L; Zheng, G; Zhou, Y	1

Other Studies

1 other study(ies) available for aica ribonucleotide and naltrexone

Article	Year
κ-opioid receptor activation protects against myocardial ischemia-reperfusion injury via AMPK/Akt/eNOS signaling activation. European journal of pharmacology, 2018, Aug-15, Volume: 833 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Line; Cell Survival; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Naltrexone; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Ribonucleotides; Signal Transduction; Troponin T	2018

Article

Year

κ-opioid receptor activation protects against myocardial ischemia-reperfusion injury via AMPK/Akt/eNOS signaling activation.

European journal of pharmacology, 2018, Aug-15, Volume: 833

Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Line; Cell Survival; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Naltrexone; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Ribonucleotides; Signal Transduction; Troponin T

2018